Avascular Necrosis clinical trials at University of California Health
5 in progress, 1 open to eligible people
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
open to eligible people ages 18-80
A prospective, single-arm, intervention study of oral alendronate in adults with sickle cell disease and osteonecrosis
at UC Davis
Insignia™ Hip Stem Outcomes Study
Sorry, in progress, not accepting new patients
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
at UCSF
Sickle Cell Disease (SCD) Bone Pain Study
Sorry, in progress, not accepting new patients
A prospective study to determine how low bone mineral density and/or vertebral compression fractures associate with pain in adults with sickle cell disease
at UC Davis
Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System
Sorry, accepting new patients by invitation only
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
at UCSF
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Sorry, in progress, not accepting new patients
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
at UCSF
Our lead scientists for Avascular Necrosis research studies include Oyebimpe O Adesina, MD, MS Erik Hansen.
Last updated: